Evogene Ltd. (EVGN) SEC filings

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30

$0.36−0.03 (-8.70%)

Close on Nov 12, 2026Market cap $3.15MP/E 0.3Yield –

SEC filings

40 of Evogene's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	6-K	Nov 10, 2026	Nov 10, 2026	SEC EDGAR
Current report	6-K	Oct 28, 2026	Oct 28, 2026	SEC EDGAR
Current report	6-K	Oct 6, 2026	Oct 6, 2026	SEC EDGAR
Current report	6-K	Sep 30, 2026	Sep 30, 2026	SEC EDGAR
Current report	6-K	Jun 30, 2026	Sep 28, 2026	SEC EDGAR
Current report	6-K	Sep 15, 2026	Sep 15, 2026	SEC EDGAR
Current report	6-K	Sep 4, 2026	Sep 4, 2026	SEC EDGAR
Current report	6-K	Aug 27, 2026	Aug 27, 2026	SEC EDGAR
Current report	6-K	Aug 18, 2026	Aug 18, 2026	SEC EDGAR
Current report	6-K	Jul 31, 2026	Jul 31, 2026	SEC EDGAR
Current report	6-K	Jul 17, 2026	Jul 17, 2026	SEC EDGAR
Current report	6-K	Jun 16, 2026	Jun 16, 2026	SEC EDGAR
Current report	6-K	Jun 11, 2026	Jun 11, 2026	SEC EDGAR
Current report	6-K	May 20, 2026	May 20, 2026	SEC EDGAR
Current report	6-K	May 18, 2026	May 18, 2026	SEC EDGAR
Current report	6-K	Apr 2, 2026	Apr 2, 2026	SEC EDGAR
Annual report	20-F	Dec 31, 2025	Mar 26, 2026	SEC EDGAR
Current report	6-K	Mar 5, 2026	Mar 5, 2026	SEC EDGAR
Current report	6-K	Feb 25, 2026	Feb 25, 2026	SEC EDGAR
Current report	6-K	Feb 11, 2026	Feb 11, 2026	SEC EDGAR
Current report	6-K	Feb 4, 2026	Feb 4, 2026	SEC EDGAR
Current report	6-K	Jan 15, 2026	Jan 15, 2026	SEC EDGAR
Current report	6-K	Dec 30, 2025	Dec 30, 2025	SEC EDGAR
Current report	6-K	Nov 20, 2025	Nov 20, 2025	SEC EDGAR
Current report	6-K	Jun 30, 2025	Sep 30, 2025	SEC EDGAR
Current report	6-K	Sep 10, 2025	Sep 10, 2025	SEC EDGAR
Current report	6-K	Aug 19, 2025	Aug 19, 2025	SEC EDGAR
Current report	6-K	Aug 18, 2025	Aug 18, 2025	SEC EDGAR
Current report	6-K	Aug 11, 2025	Aug 11, 2025	SEC EDGAR
Current report	6-K	Jul 17, 2025	Jul 17, 2025	SEC EDGAR
Current report	6-K	Jul 8, 2025	Jul 8, 2025	SEC EDGAR
Current report	6-K	Jun 17, 2025	Jun 17, 2025	SEC EDGAR
Current report	6-K	Jun 5, 2025	Jun 5, 2025	SEC EDGAR
Current report	6-K	May 21, 2025	May 21, 2025	SEC EDGAR
Current report	6-K	Apr 21, 2025	Apr 21, 2025	SEC EDGAR
Annual report	20-F	Dec 31, 2024	Mar 27, 2025	SEC EDGAR
Current report	6-K	Mar 6, 2025	Mar 6, 2025	SEC EDGAR
Current report	6-K	Mar 6, 2025	Mar 6, 2025	SEC EDGAR
Current report	6-K	Feb 12, 2025	Feb 12, 2025	SEC EDGAR
Current report	6-K	Feb 5, 2025	Feb 5, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Evogene's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Jul 25, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EVGN.

Compare: EVGN vs CBUS · EVGN vs SNES · EVGN vs DYAI · EVGN vs PRPH · EVGN vs PTCHF

Revenue growth-30.9% · median 2.7%

Gross margin-6.3% · median 16.8%

Operating margin-364.2% · median -354.1%

Net margin-220.2% · median -439.3%

Company	Revenue	Growth
CBUS	$4.53M	+19.5%
EVGN	$3.85M	-30.9%
PRPH	$3.85M	-31.2%
DYAI	$3.80M	-8.0%
SNES	$2.37M	+13.4%
PTCHF	–	–

Company

Exchange: Nasdaq
Industry: Agricultural Chemicals
Fiscal year ends: December 31
Employees: 78
Held by institutions: 3.2%
Auditor: KOST FORER GABBAY & KASIERER
SEC CIK: 1574565

Advertisement
300 × 250

See a number that looks wrong?